Fig. 3From: PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancerPRAME alters migratory potential of triple negative breast cancer cells. Migratory ability of a TNBC cells treated with siCTR or siPRAME for 72 h or b TNBC cells stably transduced with control vector or a vector encoding full length PRAME. Migration potential was measured by both the wound closure assay and the QCM™ 24-well colorimetric cell migration assay (Boyden chamber principle). **p < 0.01, *p < 0.05, n = 3 biological replicatesBack to article page